These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 23958313)

  • 1. Is there a future for cell-penetrating peptides in oligonucleotide delivery?
    Lee SH; Castagner B; Leroux JC
    Eur J Pharm Biopharm; 2013 Sep; 85(1):5-11. PubMed ID: 23958313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.
    Ming X
    Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors.
    Lindberg S; Muñoz-Alarcón A; Helmfors H; Mosqueira D; Gyllborg D; Tudoran O; Langel U
    Int J Pharm; 2013 Jan; 441(1-2):242-7. PubMed ID: 23200958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-mediated delivery: an overview of pathways for efficient internalization.
    Pae J; Pooga M
    Ther Deliv; 2014 Nov; 5(11):1203-22. PubMed ID: 25491671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-Specific Delivery of Oligonucleotides.
    Xia X; Pollock N; Zhou J; Rossi J
    Methods Mol Biol; 2019; 2036():17-50. PubMed ID: 31410789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA.
    Juliano RL
    Curr Opin Mol Ther; 2005 Apr; 7(2):132-6. PubMed ID: 15844620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan-based delivery of therapeutic oligonucleotides for treatment of human diseases.
    Ossipov DA
    Expert Opin Drug Deliv; 2019 Jun; 16(6):621-637. PubMed ID: 31072142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cell-penetrating peptides as a tool for gene regulation.
    Järver P; Langel U
    Drug Discov Today; 2004 May; 9(9):395-402. PubMed ID: 15081956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery.
    Margus H; Padari K; Pooga M
    Mol Ther; 2012 Mar; 20(3):525-33. PubMed ID: 22233581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery systems for oligonucleotide therapeutics.
    Yu B; Zhao X; Lee LJ; Lee RJ
    AAPS J; 2009 Mar; 11(1):195-203. PubMed ID: 19296227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications.
    Benizri S; Gissot A; Martin A; Vialet B; Grinstaff MW; Barthélémy P
    Bioconjug Chem; 2019 Feb; 30(2):366-383. PubMed ID: 30608140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents.
    Zatsepin TS; Turner JJ; Oretskaya TS; Gait MJ
    Curr Pharm Des; 2005; 11(28):3639-54. PubMed ID: 16305500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
    Endoh T; Ohtsuki T
    Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo biodistribution and efficacy of peptide mediated delivery.
    Järver P; Mäger I; Langel Ü
    Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A convergent uptake route for peptide- and polymer-based nucleotide delivery systems.
    Lindberg S; Regberg J; Eriksson J; Helmfors H; Muñoz-Alarcón A; Srimanee A; Figueroa RA; Hallberg E; Ezzat K; Langel Ü
    J Control Release; 2015 May; 206():58-66. PubMed ID: 25769688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
    Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
    Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.